Maclos Capital EBIT

Maclos Capital (LMSMF) currently reports a EBIT of $-77K as of December 2018. That compares with $-43K in the prior-year period — down 79.7% year over year. That is below the Healthcare sector average of $23B. Use the charts on this page to explore Maclos Capital's EBIT history and peer comparisons.

Maclos Capital's EBIT decreased from $-43K to $-77K — a 79.7% year-over-year decrease (period ending December 2018). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Maclos Capital's EBIT of $-77K is lower than the Healthcare sector average of $23B. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Maclos Capital reported $-77K in EBIT as of December 2018. That compares with $-43K in the prior-year period — down 79.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $-77K, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $23B. From there, open related valuation or income-statement pages for Maclos Capital, and consider following LMSMF for alerts when major investors trade the stock.